Cell contact by the plague bacterium Yersinia pestis initiates the injection of several virulence factors that target biochemical pathways critical for host clearance of bacteria. Despite this impairment of innate immunity, it is unclear whether antigen recognition by T cells is equally affected. We present evidence that human cytolytic T cells respond to Y. pestis virulence proteins presented by infected monocytes and dendritic cells. These T cell antigens consisted of a panel of proteins encoded by pCD1, a 70-kDa plasmid that harbors virulence factors and transport proteins of the cell contact-dependent, type III secretion system. Infected cells retained the ability to process and present tetanus toxoid to T cells, which indicates that responses to unrelated antigens were also maintained. Our results indicate that T cell immunity remains functional during Y. pestis infection, which thus suggests the potential benefits of therapeutic vaccination and strategies that emphasize the inclusion of cytotoxic T lymphocyte responses.
plague [4, 5] . A cell contact-dependent type III secretion system (TTSS) injects Yersinia outer proteins (Yops) and additional virulence factors into the cytosol, which impairs several biochemical pathways associated with innate immunity. Translocation of the TTSS-associated factors into host cells results in profound changes in cytoskeletal dynamics, signal transduction, and cell-cell communication and ultimately progresses to apoptotic cell death [6, 7] . Phagocytic cell death may allow bacteria to proliferate extracellularly [8] and to establish sequelae linked to morbidity and lethality. Furthermore, Yersinia species can survive and replicate within macrophages for a limited time [9] , perhaps during the earliest phase of disease. Thus, the potential contribution of T cells to host responses during the brief intracellular phase of plague is an unresolved issue.
Vaccines against Y. pestis infection have primarily focused on protective antibody responses to the fraction 1 capsular (CaF1) and low calcium response V (LcrV) proteins [10] [11] [12] [13] . CaF1 is an antiphagocytic factor [14] , and LcrV is a regulator of Yop production and translocation into host cells [15, 16] that may also directly contribute to virulence [17] . In addition to the reported role played by neutralizing antibody in immune protec-
Figure 1. A, Histogram of Yersinia pestis infection of monocytes (CD14 + cells) by green fluorescent protein (GFP)-transformed Y. pestis (thick line), relative to uninfected monocytes (thin line). B, Induction of apoptosis by bacterial infection. Freshly isolated monocytes were infected with Y. pestis,
permeabilized, and labeled with phycoerythrin-conjugated anti-caspase 3 (Apo 2.7) or isotype-matched control antibody. Bound antibody was measured by flow cytometry. C, Disruption of focal adhesions, cell rounding, and apoptosis caused by monocyte infection with Y. pestis. Adhered monocytes were infected with Y. pestis, fixed, and made permeable for antibody labeling. Actin microfilaments were detected with Texas red (TR)-labeled phalloidin, Toll-like receptor (TLR)-9 with specific monoclonal antibody, followed by fluorescein isothiocyanate-conjugated rabbit anti-mouse IgG, and nuclei with 4 ,6-diamidino-2-phenylindole (DAPI). Bar, 10 mm.
tion [18, 19] , cytotoxic T lymphocyte (CTL) responses to F1 have been described in mice [20] . Immunity to infection by the closely related enteropathogenic bacteria Y. enterocolitica [21, 22] and Y. pseudotuberculosis [23] is mediated by CD8 + T cells in mice. Furthermore, lysis by major histocompatibility complex class I-restricted CD8 + CTLs required the sensitization of lymphoblast target cells by extracellular adherence of Y. pseudotuberculosis to the target cell surface by the bacterial ligand invasin [23] . However, Y. pestis does not express invasin because of disruption of the gene by an insertional element [24] , which suggests that host responses might also differ in some respects from the enteropathogenic species of Yersinia. A recent publication suggested that Y. pestis disables antigen-presenting cells (APCs) and host immune responses during plague [25] . On the basis of the hypothesis that primary CTL responses might be critical for immunity, we examined mononuclear cells obtained from healthy donors with no apparent history of plague, to determine whether these primary T cell responses were impaired by the active infection of APCs. T cell responses to infected monocytes and dendritic cells (DCs) were studied using a panel of recombinant TTSS proteins encoded by pCD1, a large virulence plasmid that contains 96 open reading frames that play a pivotal role in controlling innate immunity. Although TTSS-associated proteins represent a small fraction of the 14300 total proteins produced by Y. pestis, these may be the most important for CTL-mediated immunity. Biosciences Pharmingen. The carboxyl-terminal peptide (451 aa residues) of tetanus toxin (C fragment) was purchased from Roche Applied Science. Anti-Toll-like receptor (TLR)-9 antibody was obtained from e-Biosciences. Vectashield mounting medium that contained 4 ,6-diamidino-2-phenylindole was purchased from Vector Laboratories. Texas red-phalloidin was purchased from Molecular Probes. Cell isolations and cultures. Peripheral blood mononuclear cells were obtained from consenting healthy donors, in accordance with guidelines of the institutional review boardapproved research donor protocol, and were isolated by standard density-gradient centrifugation at 400 g with Ficoll-hypaque (Pharmacia). Monocytes (CD14 + ) were isolated as described elsewhere [26] . CD14 + monocytes were incubated for 48 h with recombinant IL-15 (100 ng/mL) to prepare DCs, as described elsewhere [26] . Cell purities were 198% for the isolated mononuclear-cell subsets used in all reported experiments.
MATERIALS AND METHODS

Reagents
Infection of monocytes and T cell activation. The Y. pestis strain CO92 (pgm Ϫ , pla Ϫ ) has been described elsewhere [27] .
Bacteria were cultured (for 12 h at 37ЊC) from a single colony in heart-infusion broth (Difco Laboratories) supplemented with 0.2% xylose and 2.5 mmol/L CaCl 2 . A primed TTSS was confirmed by Western blotting of bacterial lysates and Yop-specific rabbit antibodies (R.G.U., data not shown). Bacteria were washed 3 times by centrifugation at 1600 g with RPMI 1640
medium before being used in experiments. For use in selected studies, Y. pestis CO92 (pgm Ϫ , pla Ϫ ) was transformed with pGFPuv (Invitrogen), using standard electroporation techniques, to facilitate the expression of green fluorescent protein (Yp-GFP). Monocytes were incubated (for 1 h at 37ЊC) with Yp-GFP, washed, and analyzed for the internalization of bacteria by flow cytometry. For measuring T cell activation, freshly isolated monocytes were infected (for 1 h) with Y. pestis (10 bacteria/cell), extracellular bacteria were removed, and gentamicin (10 mg/mL) was added before culturing (6 days) with autologous T cells. The T cells were isolated using paramagnetic beads coated with anti-CD3 MAbs (Miltenyi Biotech), as described elsewhere [28] . Activated cells were labeled with PEconjugated anti-CD69 antibody, FITC-conjugated anti-CD4 or anti-CD8, or isotype-matched control antibody and analyzed by flow cytometry. Cell markers of infection and TTSS activity. Freshly isolated monocytes were infected with Y. pestis (10 bacteria/cell), harvested at different time points, then permeabilized and labeled with PE-conjugated anti-caspase 3 antibody (Apo 2.7) or isotype-matched control antibody. Apo 2.7-PE antibody reacts with the mitochondrial membrane protein (7A6 antigen) when it is undergoing apoptosis [29, 30] . Antibody labeling was measured by flow cytometry. To measure focal adhesions, monocytes were layered on coverslips and allowed to adhere for 2 h. Cells were then incubated with Y. pestis (for 45 min at 37ЊC), washed, and cultured for an additional 20 min with antibiotic (RPMI 1640, 5% human AB serum, and 10 mg/mL gentamicin). The coverslips were gently washed, to remove free bacteria, and were incubated for an additional 24 h. Cells were fixed and permeabilized before analysis by confocal microscopy.
Expression and purification of Y. pestis proteins. Recombinant CaF1 was expressed in Escherichia coli and purified as described elsewhere [10] . The recombinant proteins YopH, YopM, YopK, YopE, Yersinia protein kinase (Ypk)-A, LcrG, LcrH, Yersinia secretion protein (Ysc)-M1, Yersinia modulator (Ymo)-A, YopR, translocation of Yops into eukaryotic cells (Tye)-A, YscP, and YscE were produced and characterized as described elsewhere [31] . The coding sequence for YopD was amplified from Y. pestis CO92 genomic DNA by polymerase chain reaction that used PfuTurbo (Stratagene) DNA polymerase and was cloned into the vector pDONR201 (Invitrogen). Gene inserts confirmed by DNA sequencing were cloned by recombination into the E. coli expression vector pDEST17 (Invitrogen), and plasmids were transformed into E. coli BL21 host cells (Novagen) for protein expression. All of the recombinant Yersinia proteins were expressed in E. coli BL21 (DE3) cells and purified to homogeneity using a combination of amylose-affinity chromatography and/or immobilized metal-affinity chromatography and conventional chromatographic techniques. All proteins were dialyzed in RPMI 1640 before use, and low endotoxin levels were confirmed using the limulus lysate assay. The molecular weights of the final products were confirmed by electrospray mass spectrometry, and purity and identity were confirmed by SDS-PAGE. T cell proliferation assay. For the detection of T cell proliferative responses to Yersinia antigens, CD14
+ monocytes from HLA-A2 donors were infected with Y. pestis at the start of culture (10 bacteria/cell). Gentamicin or tetracycline (10 mg/mL) was added to cultures after 2 h of infection. Monocytes were washed extensively to remove extracellular bacteria before autologous T cells were added to the culture at 24 h. Primary T cell cultures were then collected after 6 days of incubation, and CD3 + T cells were purified using anti-CD3 antibody conjugated to magnetic beads as described elsewhere [32] . After 6 days of culture with purified recombinant Yersinia antigens presented by fresh DCs (prepared as described above), cultures were pulsed with 1 mCi of [ 3 H]thymidine/well for 10 h, and proliferation was measured by harvesting the cells onto microplate unifilters and measuring radioactivity in a liquid scintillation counter (Packard).
Cytotoxicity assay. Cytotoxicity assays were performed as described elsewhere [32] . Briefly, monocytes were obtained from a consenting HLA-A2 donor. To transform monocytes to DCs, monocytes were cultured with IL-15 for 48 h, as described elsewhere [26] . Adherent cells were washed extensively, and autologous T cells were added to the culture with antigens (10 mg/mL) and incubated for 6 days. T cells were collected and used as effector cells in cytotoxicity assays. Homozygous B lymphoblasts (HLA-A2; BSM cells) were pulsed (for 1 h at 37ЊC) with Y. pestis proteins (10 mg/mL) and used as target cells ( /well) for specific effector T cells. Cultures were 3 5 ϫ 10 incubated (100 mL for 4 h), then lysed with 100 mL of a nucleotide-releasing agent (Lumi tech), followed by the addition of an ATP-monitoring agent (20 mL). Light emission was measured in a luminometer (Wallac 1420 Victor; Perkin Elmer), and specific cytotoxicity was calculated by subtracting experimental from maximum target-cell lysis.
Cytokine analysis. Cytokines in culture supernatants were measured with a CBA kit (BD Biosciences Pharmingen) using capture beads coated with antibodies specific for cytokines and flow-cytometric analysis, in accordance with the manufacturer's instructions, as described elsewhere [28] .
RESULTS
T cell recognition of monocytes and DCs infected with Y. pestis. Normal human CD14
+ monocytes were incubated with Y. pestis in culture to confirm that the TTSS was functional with these cells. Approximately 70%-80% of monocytes were consistently observed to be infected (figure 1A), as measured by monitoring the internalization of Y. pestis that stably expressed GFP. In confirmation of previous observations [28] , we noted elevated cytoplasmic levels of TLR9, an innate immune receptor of bacterial DNA. Expression of the mitochondrial membrane protein caspase 3 (7A6 antigen), a marker of the early stage of apoptosis [29, 30] , was greatly increased in infected cells, compared with uninfected controls (figure 1B), and was also an anticipated effect of Yops delivered by the TTSS. Disruption of focal adhesions, cell rounding, and apoptosis were evident, which is consistent with a perturbation of biochemical networks by bacterial infection ( figure 1C) . In addition, viable replicating bacteria were recovered from the monocytes 48 h after infection (data not shown). These observations confirmed that innate immune functions of the infected monocytes were likely impaired. We next cultured Y. pestis-infected monocytes and DCs with autologous T cells for 24 h and examined culture supernatants for levels of inflammatory cytokines (figure 2). We anticipated that the capacity of both cell types to activate primary T cell responses should converge by the end of culture, because previous studies demonstrated that monocytes infected with Y. pestis differentiated into mature DCs [28] . Increased levels of tumor necrosis factor-a and interferon-g were measured in the supernatants from cultures of both infected monocytes and myeloid-derived DCs cocultured with T cells, compared with control cultures of infected monocytes or DCs without T cells. Culture supernatants from T cells with uninfected monocytes exhibited negligible amounts of cytokines (data not shown). The majority of T cells activated by infected monocytes or DCs were CD8 + ( figure 3A and 3B [31] . A recombinant capsular CaF1 protein, an intensively studied protective antigen, was also used as a positive control. Autologous T cells were cocultured with Y. pestis-infected monocytes or DCs, and these in vitro-primed T cell cultures were then tested for recognition of secondary responses to TTSS proteins. We measured CTL responses from HLA-A2 donors using BSM target cells pulsed with individual proteins from the recombinant panel. When infected monocytes were used to prime T cell responses (figure 4, top), significant cytolysis was observed for the following proteins: YopH 2-129 , YopK, YopM, TyeA, YscM2, YscE, specific Yop chaperone (Syc)-E, LcrG, YscP, and LcrH. CTL recognition of CaF1, the protective antigen de- scribed elsewhere [10] [11] [12] [13] , was also observed. Because YscM2, although it is similar to YscM1, is expressed by Y. enterocolitica but not by Y. pestis, CTL recognition may involve a cross-reactive epitope. A similar cluster of antigens, with the exception of YscM2, YopM, and LcrH, was recognized by CTLs that were generated in culture with Y. pestis-infected DCs ( figure 4, bottom) .
Internalization of Y. pestis bacilli by both monocytes and DCs was confirmed by confocal microscopy and flow cytometry (data not shown). It was also noted that, although the chaperonebinding portion of YopH contained within YopH 2-129 was recognized by CTLs, neither the chaperone SycH nor the catalytic domain of YopH (164-468 aa) elicited a CTL response. Collectively, these results indicated that human CTL primed by infected monocytes or DCs lysed target cells pulsed with soluble proteins encoded by pCD1.
Primary T cell responses to the hydrophobic translocator protein YopD. All of the recombinant proteins studied up to this point were stable in solution. However, some pCD1-encoded factors might insert into cell membranes and are difficult to purify because of their high hydrophobicity. Because the hydrophobic protein YopD was previously shown to be partially protective in mice against lethal subcutaneous challenge with nonencapsulated Y. pestis C12 [19] , we examined T cell responses to YopD presented by infected cells. Although the recombinant protein tended to precipitate in the cell-culture medium, significant T cell proliferative responses were observed with YopD presented by infected monocytes (figure 5A), and target cells sensitized with YopD were lysed by T cells activated with infected monocytes (figure 5B) or DCs ( figure 5C ). CTLs appeared to recognize YopD-pulsed target cells better if they had been primed by infected monocytes, compared with DCs ( figure 5 , 5B vs. 5C). In addition, lower responses to the more soluble carboxy-terminal fragment of YopD, compared with the full-length protein (figure 5), suggested that CTL epitopes were contained within both the amino and carboxyl termini.
Presentation of heterologous antigens by infected monocytes. Although infected monocytes presented Y. pestis proteins to T cells, there was the possibility that presentation of other proteins by these infected APCs may have been diminished. We examined this issue by measuring T cell responses to tetanus toxoid, a common recall antigen. Monocytes were infected with Y. pestis, followed by culture with the carboxy-terminal polypeptide of tetanus toxin and autologous T cells. Our results indicated that T cells readily proliferated in response to the tetanus toxin polypeptide presented by monocytes infected with Y. pestis ( figure 5D) .
DISCUSSION
Our results demonstrate that infected monocytes and DCs stimulate naive T cells to respond to many TTSS-associated virulence factors, including those that disrupt distinct host biochemical pathways. Significant CTL recognition of CaF1, YscM2, YscE, YopH, SycE, YopK, YopM, LcrG, TyeA, YscP, and LcrH was observed. Proliferative T cell responses were also noted to CaF1 [28] , YopH, YopK (data not shown), and YopD presented by infected cells, which suggests that these antigens may be useful for inducing both CTL and T helper immunity. Fur-thermore, adaptive T cell immunity is relevant to the earliest phase of plague, because the expression of the TTSS proteins is activated by transition of the host temperature to 37ЊC, which occurs shortly after transfer from the flea vector [33] . Although TTSS factors injected into the cytosol potentially attack both innate and adaptive arms of the immune response, infected human monocytes differentiate into DCs and appear to retain many normal functions [28] .
It is perhaps surprising that T cell antigen receptors respond to potent virulence factors from Y. pestis, because the biochemical activities of these factors perturb host cell function. For example, YopH is a potent tyrosine phosphatase that attacks macrophage p130Cas, FAK proteins, and other tyrosine-phosphorylated proteins, which results in the disruption of focal adhesions [34, 35] ; YopE is a GTPase-activating protein that causes actin cytoskeleton depolymerization [36] ; and YpkA is a Ser/Thr kinase that interferes with R-mediated cellular signaling [37] . Although no specific enzymatic or other distinct biochemical activities were noted for YopM, this factor appears to target NK cells [38] , which depletes an important host defense against intracellular infection. YopK is involved in regulating the translocation of Yops through membrane channels [39] , and TyeA is required for the translocation of YopE and YopH [40] . In addition, the Ysc proteins [41] assemble into the injectosome, a macromolecular delivery system that directs the translocation of YopE, YopH, YopJ, YopM, YopT, and YpkA into the cytosol of mammalian cells [3] .
Antibody responses play an important role in protective immunity to Y. pestis. Efforts to develop vaccines against Y. pestis infection have primarily focused on CaF1 and V (LcrV) antigens and a proposed antibody-mediated mode of immune protection [13, 42] . LcrV is a secreted protein encoded by pCD1 that regulates Yop translocation into host cells and may suppress immune responses by a mechanism involving IL-10 [43] . Antibody responses to YopH, YopD, and YopM were also detected in mice challenged with pneumonic plague and rescued by antibiotic treatment [18] . CTLs and phagocytes may also be critical to bacterial clearance because of the protected intracellular growth of Y. pestis at the earliest stage of infection. The intracellular expression of YopH [44] or CaF1 [20] was previously shown to stimulate adaptive mouse CTL immunity, although the contribution to bacterial clearance is unclear.
Although all stages of plague progression are potential therapeutic targets, the earliest medical intervention will be the most effective. Phagocytosis by neutrophils, macrophages, and certain other cells; inflammatory cytokine responses triggered by pathogen-associated molecular patterns; and NK cell activity may all function in the naive host to clear invading pathogens. Manufacturing of the US-licensed, formaldehyde-killed, whole bacterial vaccine was discontinued in 1999, and there are no other vaccines available at present for plague. A proposed vaccine comprised of recombinant CaF1 and LcrV components [10] [11] [12] [13] was designed to primarily stimulate antibody responses. Circulating antibodies from vaccination or prior immunity may inhibit the delivery of Y. pestis virulence factors by promoting phagocytosis [45] . Because the intracellular phase sequesters Y. pestis from antibody contact, CTL activity and enhanced innate responses may be important for achieving sterilizing immunity, particularly in the naive host. Our results suggest a potential benefit of vaccination strategies that emphasize CTL responses, and we have identified several pCD1-derived proteins that are potential new vaccine candidates. Furthermore, we propose that the enhancement of CTL activity by therapeutic vaccination may also be useful for the treatment of infection.
